Skip to main content
Fig. 2 | BMC Complementary Medicine and Therapies

Fig. 2

From: Overcoming cisplatin resistance by targeting the MTDH-PTEN interaction in ovarian cancer with sera derived from rats exposed to Guizhi Fuling wan extract

Fig. 2

Protein Ligand interaction with LY294002 and 3-dehydrotrametenolic acid. The systemsDock website was used to predict the possible PTEN/MTDH protein ligand interaction with the compounds. a. PTEN protein ligands with 3-dehydrotrametenolic acid, b. MTDH protein ligands with 3-dehydrotrametenolic acid, c. PTEN protein ligands with LY294002, d. MTDH protein ligands with LY294002

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us